Credit Suisse Downgrades Aveanna Healthcare Hldgs to Underperform, Lowers Price Target to $1
Credit Suisse analyst A.J. Rice downgrades Aveanna Healthcare Hldgs (NASDAQ:AVAH) from Neutral to Underperform and lowers the price target from $2 to $1.